Atlas Trials

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Clinical trial NCT03444467 · COMPLETED

Trial details

NCT number
NCT03444467
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2018-02-05
Primary completion
2018-05-24
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.